1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. E-therapeutics plc
  6. News
  7. Summary
    ETX   GB00B2823H99

E-THERAPEUTICS PLC

(ETX)
  Report
Delayed London Stock Exchange  -  05/17 11:35:09 am EDT
22.80 GBX   -1.94%
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

E-therapeutics plc Reports Earnings Results for the Half Year Ended July 31, 2021

10/26/2021 | 02:01am EDT

e-therapeutics plc reported earnings results for the half year ended July 31, 2021. For the half year, the company reported sales was GBP 0.477 million compared to GBP 0.037 million a year ago. Net loss was GBP 2.79 million compared to GBP 2.35 million a year ago. Basic loss per share from continuing operations was GBP 0.0054 compared to GBP 0.0056 a year ago.


ę S&P Capital IQ 2021
All news about E-THERAPEUTICS PLC
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
05/04E-therapeutics plc Reports Earnings Results for the Full Year Ended January 31, 2022
CI
04/12E-therapeutics Achieves Key Milestones Under Collaboration with Galapagos
MT
04/05E-therapeutics Jumps 8% on Collaboration to Develop New Immuno-Oncology Therapies
MT
2021E-Therapeutics CFO to Step Down; Interim Finance Chief Named
MT
2021E-Therapeutics plc Announces Executive Changes
CI
2021Director Dealing – 26th October 2021
PU
2021E THERAPEUTICS : Interim Results, July 2021 and RNAi Platform Development Presentation
PU
More news
Financials
Sales
Net income
Net Debt
P/E ratio
Yield
Capitalization 117 M 146 M 146 M
EV / Sales -1
EV / Sales 0
Nbr of Employees 35
Free-Float 36,0%
Chart E-THERAPEUTICS PLC
Duration : Period :
e-therapeutics plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends E-THERAPEUTICS PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers and Directors
Ahmad Ali Mortazavi Chief Executive Officer & Director
Michael Anthony Bretherton Chief Financial Officer & Director
Trevor Mervyn Jones Independent Non-Executive Chairman
Alan Whitmore Chief Scientific Officer
Jonny Wray Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
E-THERAPEUTICS PLC-48.53%147
MODERNA, INC.-43.98%54 199
LONZA GROUP AG-28.13%40 453
IQVIA HOLDINGS INC.-26.74%39 077
SEAGEN INC.-5.21%26 238
ICON PUBLIC LIMITED COMPANY-32.47%17 114